Synthesis, structural characterization, in silico ADMET and molecular docking studies of a Schiff base derived from 4-hydroxybenzaldehyde and 4-aminobenzoic acid†
{"title":"Synthesis, structural characterization, in silico ADMET and molecular docking studies of a Schiff base derived from 4-hydroxybenzaldehyde and 4-aminobenzoic acid†","authors":"Patryk Nowak and Artur Sikorski","doi":"10.1039/D4NJ02791D","DOIUrl":null,"url":null,"abstract":"<p >The hemihydrate of the Schiff base derived from 4-hydroxybenzaldehyde and 4-aminobenzoic acid was synthesized and characterized using TG, ATR-FTIR, and SCXRD methods. Thermal analysis shows that the dehydration of 4-{(<em>E</em>)-[(4-hydroxyphenyl)methylidene]amino}benzoic acid hemihydrate occurs around 150 °C and yields a non-crystalline anhydrous form (m.p. = 241 °C). ATR-FTIR studies confirm the presence of an azomethine group (–HC<img>N–). SCXRD experiments revealed that the title compound crystallizes in the monoclinic <em>P</em>2<small><sub>1</sub></small>/<em>n</em> space group with two 4-(4-hydroxybenzylidene)aminobenzoic acid molecules and one water molecule in the asymmetric unit. In the crystal of the title compound, the Schiff base molecules are linked <em>via</em> O–H⋯O, O–H⋯N, and C–H⋯O hydrogen bonds, and C–H⋯π and π–π interactions. ADMET analysis indicates the synthesized compound's potential as a promising agent with high gastrointestinal absorption and the ability to cross the blood–brain barrier. Molecular docking studies predict its binding to the active sites of AChE and CA II.</p>","PeriodicalId":95,"journal":{"name":"New Journal of Chemistry","volume":" 14","pages":" 5940-5949"},"PeriodicalIF":2.7000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"New Journal of Chemistry","FirstCategoryId":"92","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2025/nj/d4nj02791d","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
The hemihydrate of the Schiff base derived from 4-hydroxybenzaldehyde and 4-aminobenzoic acid was synthesized and characterized using TG, ATR-FTIR, and SCXRD methods. Thermal analysis shows that the dehydration of 4-{(E)-[(4-hydroxyphenyl)methylidene]amino}benzoic acid hemihydrate occurs around 150 °C and yields a non-crystalline anhydrous form (m.p. = 241 °C). ATR-FTIR studies confirm the presence of an azomethine group (–HCN–). SCXRD experiments revealed that the title compound crystallizes in the monoclinic P21/n space group with two 4-(4-hydroxybenzylidene)aminobenzoic acid molecules and one water molecule in the asymmetric unit. In the crystal of the title compound, the Schiff base molecules are linked via O–H⋯O, O–H⋯N, and C–H⋯O hydrogen bonds, and C–H⋯π and π–π interactions. ADMET analysis indicates the synthesized compound's potential as a promising agent with high gastrointestinal absorption and the ability to cross the blood–brain barrier. Molecular docking studies predict its binding to the active sites of AChE and CA II.